ReviewCambridge prisms. Extinction2023
Phylogenetic diversity in conservation: A brief history, critical overview, and challenges to progress.
Review in Cambridge prisms. Extinction, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Earth's biodiversity: How much is there?Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Beyond phylogeny: phytochemical diversity as a unique metric for biodiversity in the Gentianales.The New phytologist · 2025Article
- Lineages to landscapes: mitogenomic insights and climate refugia informing proactive conservation of the endangered Tricarinate Hill Turtle (Melanochelys tricarinata) in the Indian subcontinent.Scientific reports · 2025Article
- Biodiversity conservation requires integration of species-centric and process-based strategies.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Areas of High Biodiversity Value Evidenced by the Spatial Scaling of Phylogenetic Uniqueness.Ecology letters · 2025Article
- An interdisciplinary approach to improving conservation outcomes for parasites.Conservation biology : the journal of the Society for Conservation Biology · 2025Review
- Intergenerational justice, the impending sixth mass extinction, reproduction and advanced biotechnologies, and humanity's future.Cambridge prisms. Extinction · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Species that are evolutionarily distinct have long been valued for their unique and irreplaceable contribution to biodiversity. About 30 years ago, this idea was extended to the concept of phylogenetic diversity (PD): a quantitative, continuous-scale index of conservation value for a set of species, calculated by summing the phylogenetic branch lengths that connect them. This way of capturing evolutionary history has opened new opportunities for analysis, and has therefore generated a huge academic literature, but to date has had only limited impact on conservation practice or policy. In this review, I present a brief historical overview of PD research. I then examine the empirical evidence for the primary rationale of PD that it is the best proxy for "feature diversity," which includes both known and unknown phenotypic characters, contributing to utilitarian value, ecosystem function, future resilience, and evolutionary potential. Surprisingly, it is only relatively recently that this rationale has been subject to systematic empirical scrutiny, and to date, there are mixed results on the connection between PD and phenotypic diversity. Finally, I examine the least well-studied, but potentially greatest challenge for PD: its dependence on the reliability of phylogenetic inference itself. The very few studies that have investigated this so far show that the ranking of species assemblages by their PD values can vary substantially under alternative, routine, phylogenetic methods and assumptions. If PD is to become more widely adopted into conservation decision-making, it will be important to better understand the conditions under which it performs well, and those under which it performs poorly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.